Fibromuscular dysplasia recurrence after kidney transplantation: case report

C A Benavides1, Z Csapo, K Timmins

  • 1Division of Immunology and Organ Transplantation, University of Texas Medical School at Houston, TX 77030, USA. benavides.carlos@javeriana.edu.co

Clinical Nephrology
|August 2, 2006
PubMed

Insights

Intimal fibroplasia, a rare fibromuscular dysplasia, recurred in a kidney transplant recipient. This case highlights the need to consider fibromuscular dysplasia in kidney donor selection criteria.

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Vascular Biology

Background:

  • Fibromuscular dysplasia (FMD) is a non-atherosclerotic vascular disease.
  • Intimal fibroplasia is a rare subtype of FMD, predominantly affecting renal arteries.
  • Kidney transplantation is a treatment for end-stage renal disease, but donor selection remains critical.

Observation:

  • A kidney transplant recipient experienced recurrence of intimal fibroplasia 6 months post-transplantation.
  • The donor was a living-related donor.
  • The patient received successful treatment and maintained good renal function.

Findings:

  • This case represents an extremely rare instance of intimal fibroplasia recurrence after kidney transplantation.
  • The recurrence occurred despite the graft functioning well.

Implications:

  • The findings raise critical questions about the inclusion of kidneys from donors with FMD in expanded criteria for kidney transplantation.
  • Careful donor screening and recipient monitoring are essential in cases involving FMD.
  • Further research is needed to understand the long-term outcomes and risks associated with transplanting kidneys from FMD donors.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...